[The saralasin test in the diagnosis of hypertension (author's transl)]. 1979

G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann

The saralasin test was performed in 68 hypertensives. A clear-cut dependence of the test results on initial plasma-renin concentration and particular sodium balance was demonstrated. Because of this dependence the saralasin test should be performed only under constant conditions. A mild stimulation of the renin-angiotension system by salt restriction to a mean sodium excretion of 50 mmol daily and 80 mg furosemide by mouth 12 hours before the test seems best. In this way essential and renovascular hypertension could be distinguished with considerable reliability (P less than 0.001). Among patients with essential hypertension one could clearly separate those with high plasma-renin concentration from those with a normal or low one. Among patients with renovascular hypertension those with haemodynamically significant renal artery stenosis could with high probability be distinguished from those with non-effective stenosis. A positive saralasin test without testing the function of the normal contralateral kidney does not provide an indication for operation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
February 1978, La Nouvelle presse medicale,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
November 1978, Deutsche medizinische Wochenschrift (1946),
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
January 1982, Cardiologia (Rome, Italy),
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
September 1979, Minerva cardioangiologica,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
November 1980, La Nouvelle presse medicale,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
January 1982, Cardiologia (Rome, Italy),
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
January 1979, Minerva nefrologica,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
February 1986, Zeitschrift fur Urologie und Nephrologie,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
January 1980, Bollettino della Societa italiana di cardiologia,
G Bönner, and A Helber, and K A Meurer, and W Hummerich, and G Wambach, and W Kaufmann
March 1979, Medizinische Klinik,
Copied contents to your clipboard!